Hagerty Q1 2026 Earnings NarrowerThanExpected Loss Fails to Inspire Market GT Biopharma Q1 2026 Earnings Wider Loss and No Revenue as Pipeline Progress Remains Uncertain TMHC Q1 2026 Earnings EPS Surges Past Estimates by 2856 ATXG Q1 2025 Earnings Loss per Share of 025 and Stock Decline Highlight Ongoing Challenges RRX Q1 2026 Earnings Earnings Beat on Solid Execution Amid Mixed Market Conditions CRNX Q1 2026 Earnings NarrowerThanExpected Loss Despite Ongoing Development Costs